RIM
HZNP

RS Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

RS Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,453,024
Closed -$24.1M – 426
2016
Q1 		$24.1M Sell
1,453,024
-757,424
-34% -$13.3M 0.24% 147
2015
Q4 		$47.9M Buy
2,210,448
+826,898
+60% +$16.1M 0.43% 85
2015
Q3 		$27.4M Buy
1,383,550
+419,390
+43% +$13.3M 0.24% 150
2015
Q2 		$33.5M Buy
+964,160
New +$29.4M 0.29% 137

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

RS Investment Management's HZNP Position: Q2 2016 in Review

RS Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 1,453,024 shares — an estimated $24.1M sold.

RS Investment Management first reported a position in HZNP in Q2 2015 and held it in 4 quarters. The position peaked at $47.9M in Q4 2015. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

  • RS Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • RS Investment Management sold 1,453,024 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $24.1M.
  • RS Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 4 quarters.
  • RS Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $47.9M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.